Age should not be a factor in cancer treatment

For Christmas my daughter bought me Jodie Picoult’s moving novel ‘My Sister’s keeper’, the story of a girl who is genetically selected to be born as a bone-marrow donor match to treat her older sister Kate’s leukemia. Kate relapses as a teenager and a decision has to be made about whether she should have a kidney transplant from her ‘donor’ sister.  An ethical dilemma for all, but as far as Kate is concerned, there is no discussion about her age, only whether it’s worth the risk considering her poor health.

Today’s report from Macmillan Cancer Support and the National Cancer Intelligence Network (NCIN) on the reality of long-term survivorship from cancer of those over 65 years is contrasted with the larger numbers of survivors in the EU than in the UK. For the over 65’s in the UK, our five year survival rates are lower than in comparable countries. It would seem that the adage “what do you expect at your age?” is alive and kicking in too many hospitals, where the nature of a patient’s cancer and their fitness for treatment is given secondary consideration.

Most commentators still think that age should be a consideration. Having worked with older people for 20 years I would disagree. Fitness for treatment and the nature of the cancer should be the top considerations, never age. The huge variation in well-being of the over 65s would make any fixed age-based decision completely arbitary. More so, if we open the door to age inequalities – making relative decisions based on how old someone is – the economic pressure of an ageing population means that we will inevitably become more utilitarian. A decision based on age harms us all, because it reinforces the idea that your worth is relative to your abilities, your independence and the time period for which you have already lived.  5 year survival by age

Jeremy Hunt rightly highlighted last autumn our national shame that so many older people are lonely; he talked about the ‘reverence and respect’ that he had seen for older people in Asian countries. I too have seen this in my visits to sub-Saharan Africa: older people are esteemed, yielded and listened to. We demean our society when we treat older people as inferior.

This subject isn’t going to go away. The organisation that rations our medicines, NICE, are about to start a consultation on how to allow for ‘societal benefits’ as they consider their equation for establishing the cost-effectiveness of new medicines. Last year they turned down all but one new cancer drug, hence the medical and political imperative for the Cancer Drugs Fund. And this was the concern behind the press headlines two weeks ago, stating that older people will be denied drugs as society has less to benefit from an older person compared with someone of working age.

I have already stated publicly that age should not be a consideration in the methodology of assessing new medicines, and the same goes for any treatment. If we are of value because of our humanity, then that is not age-dependent. If we start to make our value conditional on our abilities, then we embrace relativism. We would be opening the door to the discrimination that follows, wielded by those who have the most power, and we would end up with a culture of fear.

Advertisements

About Julia Manning

Julia Manning is a social entrepreneur, writer, campaigner and commentator. She is based in London and is the founder and Chief Executive of 2020health, an independent, social enterprise Think Tank whose aim is to Make Health Personal. Through networking, technology, research, relationships and campaigning 2020health has influenced opinion and action in fields as diverse as bioethics, alcohol, emerging technologies, fraud, education, consumer technology and vaccination. Julia studied visual science at City University and became a member of the College of Optometrists in 1991. Her career has included being a visiting lecturer at City University, a visiting clinician at the Royal Free Hospital, working with south London Primary Care Trusts and as a Director of the UK Institute of Optometry. She specialised in diabetes (University of Warwick Certificate in Diabetic Care) and founded Julia Manning Eyecare in 2004, a home and prison visiting practice for people with mental and physical disabilities using the latest digital technology, which she sold to Healthcall (now part of Specsavers) in 2009. Experiences of working in the NHS, contributing to policy development, raising two children in the inner-city and standing in the General Election in Bristol in 2005 led to Julia forming 2020health at the end of 2006. Julia is a regular guest on TV and radio shows such as BBC News, ITV’s Daybreak/ GMB, Channel 5 News, BBC 1′s The Big Questions, BBC Radio, LBC and has taken part in debates and contributed to BBC’s Newsnight, Panorama, You and Yours and ITV’s The Week. She is mum to a rugby-mad son, a daughter passionate about Shakespeare, and wife of a comprehensive school assistant head-teacher. She loves gardening, ballet, Zimbabwe, her Westies Skye and Angus, is an honorary research associate at UCL and a Fellow of the RSA.
This entry was posted in Bowel Cancer, Breast Cancer, Cancer, Finance and tagged , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s